SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec informs about dematerialized shares

07 May 2021 Evaluate
Panacea Biotec has informed that with reference to CDSL's Operating Instructions for Issuers/ RTAs, which states that the Issuer/ RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, the details of shares dematerialized during April, 2021 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 are enclosed.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

358.00 5.30 (1.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×